Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeGet StartedBook a Demo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Cascade Bio has raised $6M to enhance enzyme-based biomanufacturing processes and expand its breakthrough biocatalysts.

PRIVATESep 09, 2025•11 months ago

Amount Raised

$6 Million

Round Type

Seed

DenverBiotechnology

Investors

Amplify10 VcRange Ventures1 FlourishStray Dog CapitalEndurance28

Description

Cascade Bio has secured $6M to accelerate the shift from petrochemicals to biomanufacturing. The funding includes a $2.8M seed round led by Endurance28 and $3.2M in nondilutive funding from NSF. This investment will allow Cascade to expand the delivery of its high-performing enzymes. The company aims to dramatically improve costs and ease-of-use for biocatalysis in industrial applications.

Company Information

Company

Cascade Bio

Location

Denver, Colorado, United States

About

Cascade Bio is creating more productive enzymes for economical biomanufacturing of sustainable chemicals. Cascade addresses the growing need for stable, long-lasting biocatalysts using our patent-pending enzyme immobilization platform. By combining nature’s catalyst, enzymes, with state-of-the-art materials, we can create something that is greater than the sum of its parts. Join us as we help build the future bioeconomy.

Related People

Suggested for you
1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Cascade Bio's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Cascade Bio? See every signal — funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan